Really do think I'm Honestly can not find an is
Post# of 158054
(Total Views: 162)
Posted On: 10/20/2025 3:29:14 AM
Re: KenChowder #158053
Really do think I'm
Honestly can not find an issue with that line of thinking & i think it was you who said Dr. J is surely talking about the trial in a way that means --- ICI dose when/as needed
But I think for Briefing Book clarity --- they stuck to both CRC trials not including ICI
Which also does not "pressure" the FDA up-front. Let them be the decision maker & if so, that's fine because LL is the Stand Alone or Prime n Pair
The metastatic trial is choice ---- if had needed to choose
But....letting the FDA choose is similar to choosing to go Team-up with ICI's, instead of challenging them like 13D wanted to do.
ICI industry will consolidate itself anyway --- so why cause any problems
Same with this CRC/ICI --- no need to cause an appearence to the FDA of us trying to rush them into ICI before having presented..
Especially when they too, know what a No means & we have many more fish to fry, being --- a Metastatic trial
So yea, if, if im right ( sure feels like it all fits ) --- then it was a logical, good business risk. Yes sir.....
Honestly can not find an issue with that line of thinking & i think it was you who said Dr. J is surely talking about the trial in a way that means --- ICI dose when/as needed
But I think for Briefing Book clarity --- they stuck to both CRC trials not including ICI
Which also does not "pressure" the FDA up-front. Let them be the decision maker & if so, that's fine because LL is the Stand Alone or Prime n Pair
The metastatic trial is choice ---- if had needed to choose
But....letting the FDA choose is similar to choosing to go Team-up with ICI's, instead of challenging them like 13D wanted to do.
ICI industry will consolidate itself anyway --- so why cause any problems
Same with this CRC/ICI --- no need to cause an appearence to the FDA of us trying to rush them into ICI before having presented..
Especially when they too, know what a No means & we have many more fish to fry, being --- a Metastatic trial
So yea, if, if im right ( sure feels like it all fits ) --- then it was a logical, good business risk. Yes sir.....
(1)
(0)